David M. Epstein
Board Member
Gyre Therapeutics, Inc. (GYRE)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About David M. Epstein
David M. Epstein is recorded as Board Member at Gyre Therapeutics, Inc. (GYRE). David M. Epstein was last confirmed as Board Member at Black Diamond Therapeutics, Inc. (BDTX) in a filing dated April 4, 2023. Black Diamond Therapeutics, Inc. reported in an 8-K filed September 18, 2023 that David M. Epstein was terminated as President and Chief Executive Officer and principal executive officer, effective September 15, 2023. The proxy statement of Black Diamond Therapeutics, Inc. reports total compensation of $2,019,206 for David M. Epstein in fiscal 2023, including a base salary of $412,300. Disclosed compensation is on record for 5 fiscal years.
“On September 18, 2023, Black Diamond Therapeutics, Inc. (the "Company") announced that it separated with David M. Epstein, Ph.D. as President and Chief Executive Officer and principal executive officer of the Company, in each case, effective as of September 15, 2023 (the "Separation").”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
Start not stated–present
-
2016-01-01–2023-04-04
Last confirmed by a filing; no departure on record
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Gyre Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Charles Wu CEO, Board Member
- Dr. Han Ying CEO
- Dr. Ying Luo CEO, Board Member
- Ping Zhang CEO, Board Member
- Ying Luo CEO, Board Member
- Ying Luo, Ph.D. CEO, Board Member
- Augustine Lawlor Chairman, Board Member
- Songjiang Ma Chairman, Board Member
- Clinton Musil CFO
- Fletcher Payne CFO
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2023 | Black Diamond Therapeutics, Inc. (BDTX) | Ph.D. Former President and Chief Executive Officer | $412,300 | $2,019,206 |
| 2022 | Black Diamond Therapeutics, Inc. (BDTX) | Ph.D. Former President and Chief Executive Officer | $554,350 | $1,644,857 |
| 2021 | Black Diamond Therapeutics, Inc. (BDTX) | President and Chief Executive Officer | $538,201 | $5,090,225 |
| 2020 | Black Diamond Therapeutics, Inc. (BDTX) | President and Chief Executive Officer | $507,825 | $3,868,216 |
| 2019 | Black Diamond Therapeutics, Inc. (BDTX) | President and Chief Executive Officer | $428,904 | $3,346,081 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.